Department of Clinical Korean Medicine, Graduate School, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Republic of Korea.
Department of Korean Medicine, Kyung Hee University Korean Medicine Hospital at Gangdong, 892, Dongnam-ro, Gangdong-gu, Seoul, Republic of Korea.
Complement Ther Clin Pract. 2019 May;35:237-252. doi: 10.1016/j.ctcp.2019.02.015. Epub 2019 Feb 27.
The study was conducted to investigate the efficacy and safety of herbal medicine (HM) for post-stroke anxiety (PSA). Through comprehensive searches, twenty randomized controlled trials were included. Meta-analysis showed that compared to the HM group, the conventional pharmacotherapy group showed significantly lower Hamilton anxiety rating scale (HAMA) score after 1 week of treatment, but not after 2, 4, and 6 weeks of treatment, and higher HAMA score after 8 weeks and 3 months of treatment. Meanwhile, compared to the conventional pharmacotherapy alone group, the HM plus conventional pharmacotherapy group showed significantly better results in HAMA score after 2, 4, 6, and 8 weeks of treatment. HM group was associated with lower incidence of adverse events. Current evidence suggests that HM or HM plus conventional pharmacotherapy may be safe and effective in PSA patients within a certain time period. However, due to limited strength of evidence, definite conclusions are not possible.
本研究旨在探讨草药(HM)治疗中风后焦虑症(PSA)的疗效和安全性。通过全面检索,共纳入 20 项随机对照试验。荟萃分析显示,与常规药物治疗组相比,HM 组在治疗 1 周后汉密尔顿焦虑量表(HAMA)评分显著降低,但在治疗 2、4、6 周后以及治疗 8 周和 3 个月后 HAMA 评分均无明显差异;同时,与常规药物治疗组相比,HM 联合常规药物治疗组在治疗 2、4、6 和 8 周后的 HAMA 评分改善更明显。HM 组不良反应发生率较低。现有证据表明,HM 或 HM 联合常规药物治疗在一定时间内对 PSA 患者可能是安全有效的。但由于证据强度有限,尚不能得出明确结论。